Special Issue "Advances in Endocrine Pediatric Oncology"
Deadline for manuscript submissions: 15 April 2024 | Viewed by 1866
Interests: endocrine cancer; thyroid cancer; neuroendocrine cancers, differentiated thyroid cancer; anaplastic thyroid cancer; medullary thyroid cancer; radioactive iodine resistance; molecular alterations; targeted therapy; tyrosine kinase inhibitors; clinical trials; neck ultrasound, fine needle aspiration of thyroid and lymph node
Special Issues, Collections and Topics in MDPI journals
Interests: thyroid cancer; therapeutic approach; differentiated thyroid cancer; anaplastic thyroid cancer; medullary thyroid cancer; radioactive iodine resistance; molecular Alterations; targeted therapy; tyrosine kinase inhibitors; mTOR inhibitors; immunotherapy; clinical trials
Manuscript submission is now open for a new article collection: “Advances in endocrine pediatric oncology”. As the Guest Editor, and on behalf of the editorial team, I invite you to submit your research to this collection.
The aim of the collection is to bring together the latest articles of the highest quality from researchers working in the area of endocrine cancer, especially those relating to pediatric patients.
Endocrine and neuroendocrine cancers represent heterogeneous diseases that are commonly onset from endocrine cells. These neoplasms are rare at all ages and, therefore, especially in the pediatric age, may be part of genetic syndromes such as multiple endocrine neoplasia type 1 (MEN 1) or type 2 (MEN 2A and MEN 2B), Von Hippel–Lindau disease, familial hyperparathyroidism, Carney complex disease, etc.
As rare diseases, epidemiology, diagnosis and treatment are often challenging. Moreover, previous publications have concerned small series, and therefore only refer the expertise of single centers. However, in recent years, there has been an improvement in the biological and pathogenetic knowledge of these diseases and new effective drugs have been identified.
The aim of this Special Issue is to highlight current state-of-the-art approaches in addition to possible future perspectives related to epidemiological, diagnostic, prognostic, genetic and therapeutic approaches/innovations to endocrine pediatric cancer, as well as evaluate the effectiveness of the currently available therapies.
We welcome original articles, communications and reviews dealing with different aspects of endocrine pediatric cancer, with particular interest in innovative and original strategies.
The articles collected in this Special Issue will further enhance our knowledge and understanding of these rare pediatric cancers and drive the development of novel approaches.
Dr. Giulia Sapuppo
Dr. Federica Martorana
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Children is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- thyroid pediatric cancer
- endocrine cancer
- endocrine genetic syndromes
- neuroendocrine cancers
- epidemiology and risk factors
- short- and long-term outcomes
- new therapy